In cardiovascular disease, it has been found that the GPR can serve as an independent predictor of prognosis in coronary heart disease (CHD) patients undergoing percutaneous coronary intervention (PCI), and elevated GPR is associated with increased all-cause mortality and cardiovascular mortality [21]. This evidence concerns the gene ALDH18A1 and cardiovascular disorder.